LTR Pharma has been featured in Biotech Daily. The article discusses the potential for the Company to disrupt the Erectile Dysfunction (ED) market with its commercialisation plans for intra-nasal product, SPONTAN®.
The article also showcases the expertise of the team at LTR Pharma, writing:
“The company said its Mr Rodne was the former chief executive officer of Allied Medical then Admedus and now Anteris, with former Avexa chief executive officer, Admedus chief operating officer and current Cann Group chair Dr Julian Chick and Maja McGuire as nonexecutive directors.
“LTR said that Danny Zanardo would be the head of commercial operations.”